ATE73330T1 - Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen. - Google Patents

Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.

Info

Publication number
ATE73330T1
ATE73330T1 AT86304765T AT86304765T ATE73330T1 AT E73330 T1 ATE73330 T1 AT E73330T1 AT 86304765 T AT86304765 T AT 86304765T AT 86304765 T AT86304765 T AT 86304765T AT E73330 T1 ATE73330 T1 AT E73330T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions
medications
manufacture
treatment
Prior art date
Application number
AT86304765T
Other languages
English (en)
Inventor
Gabor Megyeri
Tibor Keve
Bela Stefko
Erik Bogsch
Janos Galambos
Anna Kassai
Ferenc Trischler
Eva Palosi
Dora Groo
Egon Karpati
Zsolt Szombathelyi
Laszlo Szporny
Bela Kiss
Istvan Laszlovszky
Erzsebet Lapis
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE73330T1 publication Critical patent/ATE73330T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Hydrogenated Pyridines (AREA)
AT86304765T 1985-06-21 1986-06-20 Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen. ATE73330T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU852445A HU193780B (en) 1985-06-21 1985-06-21 Process for producing 2-halogeno-6-methyl-ergol-9-ene derivatives and acid additional salts thereof
EP86304765A EP0208447B1 (de) 1985-06-21 1986-06-20 Verwendung von pharmaceutischen Zusammensetzungen für die Herstellung von Arzneimitteln für die Behandlung psychiatrischer Störungen

Publications (1)

Publication Number Publication Date
ATE73330T1 true ATE73330T1 (de) 1992-03-15

Family

ID=10959389

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86304765T ATE73330T1 (de) 1985-06-21 1986-06-20 Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.

Country Status (8)

Country Link
US (1) US4681887A (de)
EP (1) EP0208447B1 (de)
JP (1) JPS62425A (de)
AT (1) ATE73330T1 (de)
DE (1) DE3684186D1 (de)
DK (1) DK291786A (de)
FI (1) FI862636L (de)
HU (1) HU193780B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
CN103467296B (zh) * 2012-06-08 2016-03-09 上海医药工业研究院 一种3-溴-4-羟基苯甲酸甲酯的制备方法

Also Published As

Publication number Publication date
HU193780B (en) 1987-11-30
EP0208447B1 (de) 1992-03-11
JPH0368008B2 (de) 1991-10-25
FI862636A0 (fi) 1986-06-19
FI862636A7 (fi) 1986-12-22
DE3684186D1 (de) 1992-04-16
FI862636L (fi) 1986-12-22
US4681887A (en) 1987-07-21
HUT41022A (en) 1987-03-30
DK291786D0 (da) 1986-06-20
JPS62425A (ja) 1987-01-06
DK291786A (da) 1986-12-22
EP0208447A1 (de) 1987-01-14

Similar Documents

Publication Publication Date Title
NO843836L (no) Terapeutisk aktive sulfamatderivater
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
SE7705370L (sv) 12-azaprostanoinsyror
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
ATE73330T1 (de) Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
DE3683822D1 (de) Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
SE7411243L (de)
DE3362260D1 (en) (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same
FR2430230A1 (fr) Medicaments a base de derives de l'acide anthranilique
GB1193917A (en) Improvements in or relating to Heterocyclic Compounds and the Manufacture Thereof
DE69400352D1 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
ES8103725A1 (es) Procedimiento de preparacion de derivados del acido p-bife- nil-4-metil-2-buten-3-oico
ES8101062A1 (es) Procedimiento para la preparacion de nuevas ureas sustitui- das con radicales basicos.
DE3884878D1 (de) Uricosuretische Zusammensetzung.
ES8404685A1 (es) Un metodo para la preparacion de antraniloiloxialcanoatos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee